Copyright © 2022 StrategyHelix Inc. All Rights Reserved.
Global Dialysis Services Market - Outlook and Forecast 2022-2027
The global dialysis services market was valued at USD 74.08 billion in 2021, and it is projected to grow at a compound annual growth rate (CAGR) of 2.64% during the forecast period, reaching USD 86.61 billion by 2027. Market growth is driven by various factors that vary from region to region. In developed countries, the combination of high expenditure and a large population of dialysis patients contributes to market expansion. Conversely, in developing countries, government initiatives aimed at improving kidney health and the presence of a substantial patient population with chronic and acute kidney failure are key drivers of growth in the dialysis services market.
In 2021, the United States accounted for 91.11% of the market share in the North American dialysis service market. As one of the world’s leading countries, the United States has a higher prevalence of chronic kidney diseases. Approximately 1 in 7 adults in the country, totaling around 37 million people, suffer from CKD. The significant prevalence of CKD in the US can be attributed to high blood pressure and diabetes. The increasing incidence of CKD and end-stage kidney disease (ESKD) has led to higher healthcare expenditure and fueled growth in the dialysis service market. Annual spending per person with CKD aged 66 and older was more than double that of individuals without CKD. Baxter International reported in 2020 that the penetration rate for peritoneal dialysis services in the US has steadily increased since 2008 and is expected to continue growing in the future.
|No. of Pages||
USD 74.1 billion in 2020
Service, Disease, Age Group, End-User, and Geography
|No. of Companies Mentioned||
Dialysis is a crucial medical procedure that involves removing excess fluid and waste products from the blood when a patient’s kidneys are unable to function properly or adequately. The rising prevalence of conditions such as diabetes, hypertension, and infectious diseases strongly impacts kidney function. Currently, the dialysis services market is experiencing progressive growth. Key market players are showing interest in inorganic growth factors. Additionally, the COVID-19 pandemic has had an impact on the dialysis services market, bringing new dimensions to home care dialysis services.
The adoption of home dialysis services has significantly increased due to several factors, including the COVID-19 pandemic, a growing patient population, and technological advancements. The demand for home dialysis services has risen, particularly in low- and middle-income countries where the population requiring dialysis is growing rapidly. Globally, a significant number of patients lack access to kidney care, leading to millions of deaths from kidney failure each year. Home dialysis services have emerged in recent years to address this gap in access to dialysis care and services.
To alleviate the burden on healthcare services, there has been a notable shift towards mobile and ambulatory care in the dialysis services market. Dialysis services are now available outside of traditional healthcare facilities, directly at patients’ homes. The presence of mobile dialysis providers has seen rapid growth in developed countries. The increasing healthcare expenditure on dialysis services and the availability of mobile dialysis options present significant opportunities for market growth.
The market is segmented based on various factors, including service, disease, age group, end-user, and geography.
Segmentation by Service
Segmentation by Disease
Chronic Kidney Failure
Acute Kidney Failure
Segmentation by Age Group:
Less Than 60
Segmentation by End-User
Segmentation by Geography
North America – US, Canada
Europe – Germany, France, UK, Italy, Spain
APAC – China, Japan, India, South Korea, Australia
Latin America – Brazil, Mexico, Argentina
Middle East & Africa – South Africa, Saudi Arabia, Turkey
The global dialysis services market can be divided into two segments: hemodialysis and peritoneal dialysis. As of 2021, the hemodialysis segment accounted for 87.50% of the industry share in the global dialysis market. In hemodialysis, a machine removes blood from the body, filters it through an artificial kidney called a dialyzer, and returns the cleaned blood to the patient. This treatment is widely available for patients to use at home, and the demand for home hemodialysis has increased significantly during the COVID-19 pandemic.
Hemodialysis is the most commonly performed form of kidney replacement therapy worldwide, accounting for approximately 70% of all kidney replacement therapies and 89% of all dialysis procedures. Despite its drawbacks, around 90% of dialysis patients receive hemodialysis. In the United States, the average cost of hemodialysis care in the Medicare system is USD 90,000 per patient per year, totaling USD 28 billion.
The global dialysis services market can also be segmented by disease into chronic and acute kidney failure. The increasing prevalence of chronic and acute kidney failure is one of the main factors driving the adoption of dialysis services. Chronic kidney disease (CKD) affects more than 10% of the global population, contributing to the growth of this segment.
In 2021, the chronic kidney failure segment accounted for a market share of approximately 78.56% and is expected to dominate the industry in the foreseeable future. Chronic kidney failure is a major public health concern, with an increasing burden of diseases and overwhelming costs of care in many countries.
The global dialysis services market can be further segmented by age group into those above 60 and below 60 years old. The majority of dialysis patients are over 60 years old. The growing elderly population with various kidney disorders is a significant driver of the industry’s growth. The World Health Organization predicts that the population aged 60 and over will nearly double from 12% to 22% between 2015 and 2050. Additionally, the population under 60 years old is also growing rapidly and contributes to one-third of the dialysis patient population. In 2021, the above 60 age group segment accounted for approximately 77.50% of the market share.
In-center dialysis is a leading end-user segment, with a higher market share in 2021. Major players in the industry, such as DaVita Inc. and Fresenius Medical, generate significant revenue from in-center dialysis services. In 2021, around 80% of dialysis revenue and 76% of dialysis treatments provided by DaVita were from in-center dialysis.
The home dialysis segment holds a market share of 21.87% in the global dialysis services market and is expected to grow at a compound annual growth rate (CAGR) of 3.26% during the forecast period. Home-based dialysis services include home hemodialysis and peritoneal dialysis. Many dialysis service providers offer support services for patients who prefer and are able to perform dialysis at home. These support services include equipment and supplies, training, patient monitoring, on-call support, and follow-up assistance.
North America accounts for 32.56% of the market share in the global dialysis services market. It is a leading region for dialysis services due to the high prevalence of chronic kidney disease and the increasing rate of dialysis services. Factors such as higher healthcare expenditure and availability of healthcare services contribute to the region’s high consumption of dialysis services. In 2019, an estimated 40 million adults in North America had chronic kidney disorders and required dialysis services.
Following North America, Europe is a rapidly growing region with a strong presence of dialysis services networks. Its market share is expected to exceed USD 24.71 billion by 2027. The consistently increasing prevalence of end-stage kidney disease and the growing number of renal replacement therapies drive the demand for dialysis services in this region. The United Kingdom and Italy are particularly promising markets within Europe, with increasing numbers of dialysis patients.
The Asia-Pacific (APAC) region is projected to experience the highest growth rate of 4.29% in the dialysis services market. The increasing prevalence of various chronic conditions and the growing population will drive the demand for dialysis services in this region. China and India, in particular, have higher prevalences of diabetes, hypertension, and infectious diseases, leading to an increased incidence of CKD and acute kidney injury (AKI). Additionally, the implementation of country-based reimbursement plans and improved access to services are driving the industry’s growth in the APAC region.
Braun Melsungen, DaVita, Dialysis Clinic (DCI), Fresenius Medical Care, and Innovative Renal Care are prominent participants in the global dialysis services market. The market for dialysis is fiercely competitive, with a mix of local, regional, and international companies vying for market share. Furthermore, the expansive presence of major industry players and their extensive distribution networks intensifies market competition by enabling effective delivery strategies for primary dialysis services. Amidst the pandemic, key players have expanded their dialysis networks through in-center, home, and hospital-based dialysis services. This strategy has not only allowed them to establish a loyal customer base but has also contributed to significant revenue growth.
Key companies profiled in this report include B. Braun Melsungen AG, Baxter, DaVita, Dialysis Clinic, Fresenius Medical Care, Innovative Renal Care, NephroPlus, ARC Dialysis, Apollo Dialysis, Allmed Medical Care, ADMS (Atlantic Dialysis Management Services), Apex Kidney Care, Centers for Dialysis Care, Diaverum Deutschland, Dialife SA, KfH Kidney Centre, Northwest Kidney Centers, Rogosin Institutes, PREMIER DIALYSIS, Satellite Healthcare, Sanderling Healthcare, Terumo, US Renal Care.
Recent Industry Developments
In 2022, Fresenius Medical Care announced a new agreement to establish an independent company that will bring together various health partners, including Fresenius Medical Care, the leading patient engagement data platform Cricket Health in the United States, and InterWell Health. This merger aims to leverage the combined expertise of these partners in kidney care.
On January 25, 2021, American Renal Associates successfully completed a transaction with Innovative Renal Care.
In 2019, US Renal Care reached an agreement to be acquired by Bain Capital Private Equity and Summit Partners, a private investor group.
In 2018, NephroPlus, an India-based company specializing in kidney care, acquired the business segment of DaVita Care in India, which had been at the forefront of kidney care. As part of the acquisition agreement, NephroPlus obtained approximately 22 centers from DaVita Care (India).
Key Questions Answered
How large is the dialysis services market in terms of value?
The dialysis services market was valued at USD 74.08 billion in 2021 and is projected to reach USD 86.61 billion by 2027. The market growth is driven by several factors, including the growing preference for home dialysis and mobile dialysis service providers, as well as increasing government initiatives focused on kidney health.
What is the growth rate of the dialysis services market?
The dialysis services market is expected to grow at a compound annual growth rate (CAGR) of 2.64% from 2021 to 2027. This growth is primarily fueled by factors such as high expenditure capacity and a large population of patients requiring dialysis in developed countries.
Which region is expected to dominate the global dialysis services market?
The North America region is one of the key players in the global dialysis services market. It has a high prevalence of chronic kidney disease and an increasing rate of dialysis services. Additionally, the availability of healthcare services and higher healthcare expenditure contribute to the region’s dominant position in the market.
What is the size of the dialysis market in the United States?
The United States holds a significant market share of 91.11% in the North American dialysis services market. The penetration of dialysis services in the US is consistently growing. Factors such as a high prevalence of chronic kidney diseases, along with conditions like heart disease and a family history of kidney failure, contribute to the market’s growth in the country.
Which companies are the key players in the global dialysis services market?
The key players in the global dialysis services market include B. Braun Melsungen AG, Baxter, DaVita, Dialysis Clinic, Fresenius Medical Care, Innovative Renal Care, and NephroPlus. These companies play a crucial role in shaping the market landscape and providing dialysis services worldwide.
What are the factors that drive the growth of the dialysis services market?
The growth of the dialysis services market is driven by several factors, including the increasing prevalence of chronic kidney disease and end-stage kidney disease, the rising number of initiatives focused on kidney care, and the growing trend of mergers and acquisitions within the dialysis service industry. These factors contribute to the expansion and development of the market.